From: APAP::WALTERKU 30-JUN-1997 09:43:57.32 To: IRK CC: Subj: Seminar Colin Warner From: IN%"rcg2@york.ac.uk" "Colin Garner" 6-JUN-1997 10:33:11.46 To: IN%"WALTERKU@Pap.UniVie.AC.AT" CC: IN%"rcg2@york.ac.uk", IN%"jmd4@york.ac.uk" Subj: RE: visit to VERA Return-path: Received: from lendal.york.ac.uk (lendal.york.ac.uk) by Pap.UniVie.AC.AT (PMDF V5.0-4 #10670) id <01IJQZC97UFKE0IKA9@Pap.UniVie.AC.AT> for WALTERKU@Pap.UniVie.AC.AT; Fri, 06 Jun 1997 10:32:51 +0100 (MET) Received: from mailer.york.ac.uk by lendal.york.ac.uk with SMTP (PP); Fri, 06 Jun 1997 09:30:37 +0100 Received: from biolpc85.york.ac.uk by mailer.york.ac.uk via SMTP (950511.SGI.8.6.12.PATCH526/940406.SGI) id JAA08599; Fri, 06 Jun 1997 09:32:24 +0100 Date: Fri, 06 Jun 1997 09:34:16 -0300 (BST) From: Colin Garner Subject: Re: visit to VERA To: WALTERKU@Pap.UniVie.AC.AT Cc: rcg2@york.ac.uk, jmd4@york.ac.uk Message-id: MIME-version: 1.0 Content-type: TEXT/PLAIN; CHARSET=US-ASCII Content-transfer-encoding: 7BIT Priority: Normal Dear Professor Kutschera I have now finalised my arrangements for the visit to VERA. I will arrive in Vienna on Monday 21 July and depart 23 July. I will be accompanied by Dr Doug Watson from the Department of Physics. I have booked accomodation at the Stephanie Hotel in the centre of Vienna for the both of us. Please could you let me know at what time you would like us to arrive on July 22. Below is a copy of an Abstract of my talk. I look forward to meeting you and your colleagues. With best wishes Colin Garner ACCELERATOR MASS SPECTROMETRY - AN ANALYTICAL TOOL FOR BIOMEDICAL RESEARCH Professor Colin Garner, Director, The Jack Birch Unit for Environmental Carcinogenesis, Department of Biology, University of York, Helsington, York YO1 5DD, United Kingdom Accelerator mass spectrometry (AMS), has been used for a variety of research applications including nuclear physics, earth sciences, climatology and archaeology. Its' use in the biomedical area is only now beginning to be exploited. AMS has a number of useful attributes for biomedical research (i) the exquisite sensitivity to analyse isotopes of medical importance such as 14carbon, 129iodine, 41calcium and 36aluminium (b) the high precision of the measurements (c) the availability of commercial instruments. At the University of York we have been collaborating with the Centre for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, USA on research programmes studying human tissues and body fluids. Human subjects have been dosed with radiocarbon labelled environmental carcinogens and pharmaceuticals to study their biotransformation. My talk will illustrate some of the results of this research as well as explaining the function of the newly created York Centre for Biomedical Accelerator Mass Spectrometry.